Key Points
- Omada Health President Wei-Li Shao sold 4,036 shares at an average price of $21.85, totaling $88,186.60. The sale reduced Shao’s direct holdings by 1.35% to 295,313 shares.
- Omada reported quarterly EPS of $0.08, beating the consensus estimate of a $0.02 loss, while revenue of $87.83 million exceeded expectations of $80.93 million.
- Analysts maintain a generally positive outlook, with 11 Buy ratings, two Holds and one Sell; the stock has a “Moderate Buy” consensus rating and an average price target of $26.67.
Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) President Wei-Li Shao sold 4,036 shares of the firm's stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $21.85, for a total transaction of $88,186.60. Following the completion of the sale, the president directly owned 295,313 shares in the company, valued at approximately $6,452,589.05. This trade represents a 1.35% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
Wei-Li Shao also recently made the following trade(s):
- On Wednesday, August 12th, Wei-Li Shao sold 8,866 shares of Omada Health stock. The shares were sold at an average price of $25.02, for a total transaction of $221,827.32.
Omada Health Trading Up 4.3%
Omada Health stock opened at $20.50 on Tuesday. The firm has a market cap of $1.26 billion, a P/E ratio of 410.00 and a beta of 1.86. Omada Health, Inc. has a 1-year low of $10.28 and a 1-year high of $26.92. The firm has a 50-day moving average of $22.58 and a 200-day moving average of $18.03.
Omada Health (NASDAQ:OMDA - Get Free Report) last announced its quarterly earnings results on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.02) by $0.10. The company had revenue of $87.83 million for the quarter, compared to the consensus estimate of $80.93 million. Omada Health had a return on equity of 2.60% and a net margin of 1.39%. Research analysts forecast that Omada Health, Inc. will post 0.09 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in OMDA. Versant Capital Management Inc boosted its position in shares of Omada Health by 319.3% during the second quarter. Versant Capital Management Inc now owns 2,998 shares of the company's stock valued at $66,000 after purchasing an additional 2,283 shares in the last quarter. Integrated Wealth Concepts LLC bought a new position in Omada Health in the second quarter worth $53,000. Legal & General Group Plc purchased a new position in Omada Health during the second quarter valued at $76,000. California State Teachers Retirement System lifted its position in Omada Health by 465.1% during the second quarter. California State Teachers Retirement System now owns 10,229 shares of the company's stock valued at $225,000 after buying an additional 8,419 shares during the period. Finally, Sectoral Asset Management Inc. boosted its holdings in shares of Omada Health by 32.7% during the 4th quarter. Sectoral Asset Management Inc. now owns 36,500 shares of the company's stock valued at $576,000 after buying an additional 9,000 shares in the last quarter.
Wall Street Analyst Weigh In
A number of equities analysts recently commented on the company. Wall Street Zen upgraded Omada Health from a "hold" rating to a "buy" rating in a report on Saturday, August 8th. Robert W. Baird lifted their price target on shares of Omada Health from $15.00 to $25.00 and gave the company a "neutral" rating in a report on Wednesday, August 12th. Needham & Company LLC reissued a "buy" rating and set a $28.00 price objective on shares of Omada Health in a research report on Friday. BTIG Research restated a "buy" rating and issued a $35.00 price objective on shares of Omada Health in a report on Friday. Finally, Citizens Jmp lifted their target price on shares of Omada Health from $27.00 to $32.00 and gave the company a "market outperform" rating in a research note on Friday, August 14th. Eleven equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $26.67.
Get Our Latest Stock Report on OMDA
About Omada Health
(
Get Free Report)
Omada Health, Inc is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines clinical care, health coaching, connected devices, digital tools and personalized support to help members improve health outcomes and manage conditions over time.
The company's offerings address areas including diabetes, hypertension, weight health and musculoskeletal conditions. Omada's programs are designed to support prevention and ongoing care through services such as remote monitoring, personalized health guidance, educational content and access to healthcare professionals.
Omada primarily serves members through employers, health plans and healthcare organizations in the United States.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
